StockWatch
·
Commodity Chemicals
AGM/EGM4 Sept 2026, 05:50 pm

Emmessar Biotech Announces 34th AGM on Sep 29, 2026

AI Summary

Emmessar Biotech & Nutrition Ltd. has announced its 34th Annual General Meeting (AGM) to be held on September 29, 2026, via Video Conferencing. The agenda includes the adoption of the Audited Financial Statements for the fiscal year ended March 31, 2026, the re-appointment of Mr. Jeyavel B. Nadar as a Director, and the re-appointment of Mr. Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director for a further period of five years. The company also provided details on the proposed remuneration and terms for the Managing Director's reappointment.

Key Highlights

  • AGM scheduled for September 29, 2026, via VC/OAVM.
  • Adoption of Audited Financial Statements for FY 2025-26.
  • Re-appointment of Mr. Jeyavel B. Nadar as Director.
  • Re-appointment of Mr. S.R.M. Ayyangar as MD for 5 years.
  • Details on MD's remuneration and terms provided.